Nuwellis, Inc. (NUWE) stock
NUWENasdaqElectromedical & Electrotherapeutic ApparatusFiscal year ends December 31
$3.89−0.21 (-5.12%)
Close on Nov 18, 2026Market cap $2.23MP/E –Yield –
Nuwellis free cash flow
Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.
Nuwellis's free cash flow for the twelve months ending Jun 30, 2026 was -$12.59M. For fiscal 2025 it was -$10.90M. The highest annual figure on record is -$9.65M in fiscal 2024.
Annual free cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$10.90M | – |
| FY2024 | Dec 31, 2024 | -$9.65M | – |
| FY2023 | Dec 31, 2023 | -$18.09M | – |
| FY2022 | Dec 31, 2022 | -$15.27M | – |
| FY2021 | Dec 31, 2021 | -$18.06M | – |
| FY2020 | Dec 31, 2020 | -$16.87M | – |
| FY2019 | Dec 31, 2019 | -$16.86M | – |
| FY2018 | Dec 31, 2018 | -$14.76M | – |
| FY2017 | Dec 31, 2017 | -$12.18M | – |
| FY2016 | Dec 31, 2016 | -$16.41M | – |
| FY2015 | Dec 31, 2015 | -$23.19M | – |
| FY2014 | Dec 31, 2014 | -$23.00M | – |
| FY2013 | Dec 31, 2013 | -$17.66M | – |
| FY2012 | Dec 31, 2012 | -$13.24M | – |
| FY2011 | Dec 31, 2011 | -$13.54M | – |
Quarterly free cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$3.18M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.14M | – |
| Q4 FY2025 | Dec 31, 2025 | -$3.02M | – |
| Q3 FY2025 | Sep 30, 2025 | -$3.25M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.10M | – |
| Q1 FY2025 | Mar 31, 2025 | -$2.54M | – |
| Q4 FY2024 | Dec 31, 2024 | -$1.53M | – |
| Q3 FY2024 | Sep 30, 2024 | -$2.46M | – |
| Q2 FY2024 | Jun 30, 2024 | -$2.78M | – |
| Q1 FY2024 | Mar 31, 2024 | -$2.89M | – |
| Q4 FY2023 | Dec 31, 2023 | -$2.72M | – |
| Q3 FY2023 | Sep 30, 2023 | -$3.95M | – |
| Q2 FY2023 | Jun 30, 2023 | -$5.30M | – |
| Q1 FY2023 | Mar 31, 2023 | -$6.12M | – |
| Q4 FY2022 | Dec 31, 2022 | -$3.15M | – |
| Q3 FY2022 | Sep 30, 2022 | -$3.28M | – |
| Q2 FY2022 | Jun 30, 2022 | -$3.95M | – |
| Q1 FY2022 | Mar 31, 2022 | -$4.90M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.18M | – |
| Q3 FY2021 | Sep 30, 2021 | -$4.54M | – |
| Q2 FY2021 | Jun 30, 2021 | -$3.90M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.44M | – |
| Q4 FY2020 | Dec 31, 2020 | -$3.50M | – |
| Q3 FY2020 | Sep 30, 2020 | -$4.54M | – |
| Q2 FY2020 | Jun 30, 2020 | -$3.32M | – |
| Q1 FY2020 | Mar 31, 2020 | -$5.51M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.06M | – |
| Q3 FY2019 | Sep 30, 2019 | -$3.77M | – |
| Q2 FY2019 | Jun 30, 2019 | -$4.08M | – |
| Q1 FY2019 | Mar 31, 2019 | -$4.95M | – |
| Q4 FY2018 | Dec 31, 2018 | -$2.74M | – |
| Q3 FY2018 | Sep 30, 2018 | -$3.42M | – |
| Q2 FY2018 | Jun 30, 2018 | -$3.51M | – |
| Q1 FY2018 | Mar 31, 2018 | -$5.09M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.20M | – |
| Q3 FY2017 | Sep 30, 2017 | -$3.26M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.10M | – |
| Q1 FY2017 | Mar 31, 2017 | -$1.61M | – |
| Q4 FY2016 | Dec 31, 2016 | -$2.74M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.51M | – |
See a number that looks wrong?